Literature DB >> 9101384

Glucocorticoid-induced muscle atrophy. The role of exercise in treatment and prevention.

T K LaPier1.   

Abstract

Glucocorticoids have catabolic effects on skeletal muscle. These effects demonstrate fiber type specificity: Type IIB fibers are most susceptible and type I fibers least susceptible to the atrophy effects of glucocorticoids. Exercise training has been used frequently to counteract glucocorticoid-induced muscle atrophy. Studies have demonstrated that both resistance exercise and endurance exercise are effective in attenuating this atrophy. The cellular mechanisms mediating the attenuating effect of exercise on glucocorticoid-induced atrophy are not completely understood. More research is needed to further elucidate the details of these mechanisms and to determine the most efficacious exercise protocols for deterring glucocorticoid-induced muscle atrophy. Exercise evaluation of patients with glucocorticoid-induced myopathy and subsequent exercise prescription must be individualized and based on the patient's initial muscle function and medical status.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101384     DOI: 10.1097/00008483-199703000-00002

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  26 in total

1.  A Randomized Trial of an Intensive Physical Therapy Program for Patients with Acute Respiratory Failure.

Authors:  Marc Moss; Amy Nordon-Craft; Dan Malone; David Van Pelt; Stephen K Frankel; Mary Laird Warner; Wendy Kriekels; Monica McNulty; Diane L Fairclough; Margaret Schenkman
Journal:  Am J Respir Crit Care Med       Date:  2016-05-15       Impact factor: 21.405

Review 2.  Exercise following heart transplantation.

Authors:  R W Braith; D G Edwards
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

Review 3.  Steroid myopathy: some unresolved issues.

Authors:  M A Minetto; F Lanfranco; G Motta; S Allasia; E Arvat; G D'Antona
Journal:  J Endocrinol Invest       Date:  2011-05       Impact factor: 4.256

4.  Adherence of stem cell transplant recipients receiving glucocorticoid therapy to an exercise-based rehabilitation program.

Authors:  G Stephen Morris; Kevin E Brueilly; Janet S Scheetz; Marcos J de Lima
Journal:  Support Care Cancer       Date:  2011-12-28       Impact factor: 3.603

Review 5.  Interaction between bone and muscle in older persons with mobility limitations.

Authors:  L Ferrucci; M Baroni; A Ranchelli; F Lauretani; M Maggio; P Mecocci; C Ruggiero
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 6.  Managing Disease and Therapy-Related Complications in Patients with Central Nervous System Tumors.

Authors:  Jeffrey J Raizer; Karan S Dixit
Journal:  Curr Treat Options Oncol       Date:  2015-08

Review 7.  Prevention and treatment of systemic glucocorticoid side effects.

Authors:  Siamak Moghadam-Kia; Victoria P Werth
Journal:  Int J Dermatol       Date:  2010-03       Impact factor: 2.736

8.  Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival.

Authors:  Amro Mohamed Sedky El-Ghammaz; Rima Ben Matoug; Maha Elzimaity; Nevine Mostafa
Journal:  Support Care Cancer       Date:  2017-04-24       Impact factor: 3.603

9.  Effect of controllable stress on myosin heavy chain expression and muscle-specific protection by clomipramine.

Authors:  J M Martrette; N Hartmann; A Westphal; M Divry
Journal:  J Muscle Res Cell Motil       Date:  1998-10       Impact factor: 2.698

10.  Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline.

Authors:  X Kostaras; F Cusano; G A Kline; W Roa; J Easaw
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.